Cargando…
Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)
Antibody-drug conjugates (ADCs) have become a promising targeted therapy strategy that combines the specificity, favorable pharmacokinetics and biodistributions of antibodies with the destructive potential of highly potent drugs. One of the biggest challenges in the development of ADCs is the applic...
Autores principales: | Yao, Houzong, Jiang, Feng, Lu, Aiping, Zhang, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783928/ https://www.ncbi.nlm.nih.gov/pubmed/26848651 http://dx.doi.org/10.3390/ijms17020194 |
Ejemplares similares
-
ANTIBODY DRUG CONJUGATES (ADCS)
por: Terpos, E.
Publicado: (2023) -
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
por: Hoffmann, Ricarda M., et al.
Publicado: (2017) -
Potential of antibody–drug conjugates (ADCs) for cancer therapy
por: Marei, Hany E., et al.
Publicado: (2022) -
Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
por: Janthur, Wolf-Dieter, et al.
Publicado: (2012) -
Linkers Having a Crucial Role in Antibody–Drug Conjugates
por: Lu, Jun, et al.
Publicado: (2016)